Clinical Trial Update: Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating recombinant human luteinizing hormone before ovarian stimulation in poor ovarian responders has completed, sponsored by Inst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Recombinant human luteinizing hormone (lutropin alfa)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI Alicante | Conditions: Infertility, Female | Phase 3 | Status: COMPLETED